help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism Vol. 53, No. 1 184-191
doi:10.1210/jcem-53-1-184
Copyright © 1981 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by VALK, T. W.
Right arrow Articles by MARSHALL, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by VALK, T. W.
Right arrow Articles by MARSHALL, J. C.

Pulsatile Gonadotropin-Releasing Hormone in Gonadotropin Deficient and Normal Men: Suppression of Follicle-Stimulating Hormone Responses by Testosterone*

TIMOTHY W. VALK, KEVIN P. CORLEY, ROBERT P. KELCH and JOHN C. MARSHALL

Divisions of Endocrinology and Metabolism, Departments of Internal Medicine and Pediatrics, and the Reproductive Endocrinology Program, University of Michigan Ann Arbor, Michigan 48109

Address correspondence and requests for reprints to: John C. Marshall, M.D., R3044 Kresge II, Box 56, University Hospital, Ann Arbor, Michigan 48109.

To determine the role of testosterone (T) in modulating gonadotropin secretion during sexual maturation, we studied males with isolated gonadotropin deficiency (IGD) before and during T therapy and compared the results to those in normal men. Low dose (0.025 jug/kg) pulses of gonadotropinreleasing hormone (GnRH) were given every 2 h for 5 days to four males with IGD pretreated with T (IGD-T), and responses were compared to untreated IGD men. The same protocol was performed in four normal men. All IGD males had low gonadotropins on day 0. The mean preinjection LH and FSH rose to 4.4 ± 0.4 and 15.5 ± 2.5 mlU/ml, respectively, on day 5 in the IGD patients, while plasma T levels remained low (0.7 ± 0.2 ng/ml). T therapy, which produced adult plasma T levels, suppressed the rise in gonadotropins, particularly the FSH response. Preinjection LH and FSH levels on day 5 in the IGD-T patients were 2.5 ± 0.4 and 2.9 ± 1.0 mlU/ml, respectively. In normal men the GnRH-induced LH increments were of similar magnitude to the spontaneous LH peaks present on the control day 0. Projected LH and FSH, however, rose by 65% and 45%, respectively, during days 1 and 2 of GnRH pulses, before declining on day 3 when plasma T (7.2 ± 1.4 ng/ml) and estradiol (64 ± 7 pg/ml) were significantly elevated above the control day. Standard GnRH tests (2.5 jitg/kg), performed before and after the GnRH pulses, showed augmentation of the LH and FSH responses in IGD and to a lesser degree in IGD-T patients. In contrast, normal men showed a marked reduction in gonadotropin responses. The results in GnRH-deficient patients indicate that T treatment inhibits FSH, and to a lesser extent LH secretion, by a direct action on the pituitary gland. A similar mechanism, where increasing gonadal steroid concentrations limit pituitary responses, may explain the small FSH increase to GnRH pulses in normal men. These data suggest an explanation for the patterns of LH and FSH responses to GnRH seen during spontaneous sexual maturation in males. During normal development the rising plasma T inhibits pituitary FSH secretion, so that FSH responses remain small and the marked FSH secretion seen in IGD patients does not occur.

* This work was supported by Grant HD12306 and Clinical Research Center Grant 5MO1RR-42, Division of Research Resources, NIH, and was presented in part at the 62nd Annual Meeting of The Endocrine Society, Washington, D.C., June 17-20,1980.

Received July 28, 1980.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
J. D. Veldhuis, S. M. Pincus, R. Mitamura, K. Yano, N. Suzuki, Y. Ito, Y. Makita, and A. Okuno
Developmentally Delimited Emergence of More Orderly Luteinizing Hormone and Testosterone Secretion during Late Prepuberty in Boys
J. Clin. Endocrinol. Metab., January 1, 2001; 86(1): 80 - 89.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
U. B. Kaiser, E. Sabbagh, B. D. Saunders, and W. W. Chin
Identification of cis-Acting Deoxyribonucleic Acid Elements That Mediate Gonadotropin-Releasing Hormone Stimulation of the Rat Luteinizing Hormone {beta}-Subunit Gene
Endocrinology, May 1, 1998; 139(5): 2443 - 2451.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Foresta, P. Bordon, M. Rossato, R. Mioni, and J. D. Veldhuis
Specific Linkages Among Luteinizing Hormone, Follicle-Stimulating Hormone, and Testosterone Release in the Peripheral Blood and Human Spermatic Vein: Evidence for Both Positive (Feed-Forward) and Negative (Feedback) Within-Axis Regulation
J. Clin. Endocrinol. Metab., September 1, 1997; 82(9): 3040 - 3046.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. D. Veldhuis, A. Iranmanesh, E. Samojlik, and R. J. Urban
Differential Sex Steroid Negative Feedback Regulation of Pulsatile Follicle-Stimulating Hormone Secretion in Healthy Older Men: Deconvolution Analysis and Steady- State Sex-Steroid Hormone Infusions in Frequently Sampled Healthy Older Individuals
J. Clin. Endocrinol. Metab., April 1, 1997; 82(4): 1248 - 1254.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1981 by The Endocrine Society